Stocksigma LogoStocksigma Logo

Biogen Pharmachem Reports Nil Unutilised Issue Proceeds as of Sep'26

Biogen Pharmachem Industries Limited submitted its disclosure under Regulation 32(1) of SEBI LODR Regulations to BSE on 3rd Nov'26

Biogen Pharmachem Reports Nil Unutilised Issue Proceeds as of Sep'26

Biogen Pharmachem Industries Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 8:56 pm

Biogen Pharmachem Reports Nil Unutilised Issue Proceeds as of Sep'26 Biogen Pharmachem Industries Limited submitted its disclosure under Regulation 32(1) of SEBI LODR Regulations to BSE on 3rd Nov'26. The company confirmed that it has no unutilised funds remaining as of 30th Sep'26 or as of the filing date from any previous public issues, rights issues, preferential issues, or qualified institutional placements (QIPs). Consequently, no statement of deviation or variation was required under Annexure-A.

Original exchange filing (PDF)

More announcements from Biogen Pharmachem Industries Ltd

All Biogen Pharmachem Industries Ltd announcements